Impact of Elevated Plasma Total Homocysteine Concentration on Coronary Atherosclerosis in Chinese Patients With Acute Myocardial Infarction Undergoing Primary Coronary Intervention

Abstract

SUMMARYElevated plasma total homocysteine (tHcy) has been considered to be a new risk factor for coronary atherosclerotic disease. However, the association has not been proven indisputably, and the strength of the relationship and the interaction of plasma tHcy with other conventional risk factors remain uncertain in the clinical setting of acute myocardial infarction (AMI). The aim of this study was to investigate whether an elevated plasma level of tHcy is an independent predictor of the late stage of coronary atherosclerotic lesions in Chinese patients with AMI, who are undergoing primary percutaneous coronary intervention (PCI).Plasma levels of tHcy were prospectively measured in 178 consecutive patients with ST-segment elevated AMI undergoing primary PCI. The plasma level of tHcy was also measured in 30 control subjects with normal coronary angiographic findings. The plasma level of tHcy was significantly higher in the patients with AMI than in control subjects (10.5 ± 3.3 µmol/L versus 8.3 ± 2.4 µmol/L, P = 0.0004). Multiple stepwise logistic regression analysis of the baseline characteristics demonstrated that smoking (P = 0.004) and creatinine level (P < 0.0001) were independent predictors of an elevated plasma level of tHcy. Moreover, an increased plasma level of tHcy (P = 0.003), female gender (P = 0.008), diabetes mellitus (P = 0.020), and the presence of previous myocardial infarction (P = 0.003) were independent predictors of the late stage of multivessel diffuse atherosclerosis (defined by ≥ 2 epicardial vessels with moderate or severe diffuse atherosclerosis). In conclusion, this investigation supports the hypothesis that a raised homocysteine concentration is a strong risk factor for the late stage of diffuse coronary atherosclerosis From the

High Homocysteine Levels Predict the Recurrence of Atrial Fibrillation After Successful Electrical Cardioversion

“…[7][8][9]19) We were not able to investigate the cause of elevated Hcy levels in our patients. We also did not notice any major clinical adverse events, probably due to the small study group and relatively short observation period.…”

Relationship Between Plasma Homocysteine Levels and Congestive Heart Failure in Patients With Acute Myocardial Infarction Homocysteine and Congestive Heart Failure

“…[3][4][5][6][7][8][9][10][11][12][13][14] Many issues regarding the mechanism of action of homocysteine in the pathogenesis of arteriosclerosis and thrombotic diseases remain unclear. However, possible causes include vascular endothelial dysfunction, [17][18][19][20][21][22] smooth muscle cell growth, [23][24][25] and an increase in blood clotting activity in vascular walls.…”

“…[3][4][5][6][7][8] A high plasma homocysteine level has been shown to promote arteriosclerosis and to be an independent risk factor in the development of cardiovascular disease. [9][10][11][12][13][14] In a cohort of patients in the Framingham Heart study, a high plasma homocysteine level was shown to be a predictor of heart failure in adults who had not yet experienced myocardial infarction. 15) However, the relationship between heart failure and homocysteine levels in patients with AMI has not been reported.…”

Homocistéina e metilenotetrahidrofolato redutase em indivíduos submetidos à angiografia coronariana

“…In the Brazilian population, characterized by ethnic heterogeneity 21 , the results of studies involving plasma homocysteine levels and CAD are equally controversial. It is well to point out that most authors consider hyperhomocysteine as an independent risk factor for CAD 22 . Table 1 shows that plasma homocysteine levels were significantly higher in patients with severe atheromatosis, compared with the control group (p < 0.001).…”